UPDATE 1-Pfizer, Innovent GLP-1 drugs added to China national insurance for diabetes

1

(Recasts; adds details, context throughout) SHANGHAI/BEIJING, Nov 14 (Reuters) – GLP-1 drugs from Pfizer and Innovent Biologics will be added to China's state-run health insurance scheme from January

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)